PharmaCyte Biotech
PMCB
PMCB
24 hedge funds and large institutions have $710K invested in PharmaCyte Biotech in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
8
Closed
1
Calls
$17K
Puts
$3K
Net Calls
+$14K
Net Calls Change
+$7K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$12.6K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$4.09K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.66K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.24K |
| 5 |
Renaissance Technologies
New York
|
+$250 |
